Skip to content

Ultrasound monitoring of tissue changes in patients at risk of developing pressure ulcers: an exploratory study

Ultrasound monitoring of tissue changes in patients at risk of developing pressure ulcers: an exploratory study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN66819676
Enrollment
125
Registered
2007-04-30
Start date
2007-06-04
Completion date
Unknown
Last updated
2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure ulcers (PUs) Skin and Connective Tissue Diseases Pressure ulcers (PUs)

Interventions

The seating interface and both heels of inpatients at the Royal Hospitals will be scanned by a trained researcher using the EPISCAN 1-200 (LongPort, Inc. [USA]) High Frequency Ultrasound Scanner (HFUS

Sponsors

Department for Employment and Learning (UK) - Strategic Priority Fund
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inpatients admitted to the acute wards for vascular disease 2. Written informed consent to participate 3. Intact skin on one or more areas to be scanned (seating interface and both heels)

Exclusion criteria

Exclusion criteria: Existing pressure damage of more than or equal to Grade two visible on their skin (including blisters, abrasions, and ulcers where skin loss is present) on both heels and the seating interface.

Design outcomes

Primary

MeasureTime frame
Presence or absence of a PU (more than or equal to grade two) after baseline assessment and before discharge. Previous work has demonstrated that Clinical Research Nurses are able to identify and record the presence of a PU (more than or equal to grade two) in a consistent and reliable manner, and that initial training and clinical skill is maintained over time.

Secondary

MeasureTime frame
Development of non-blanchable erythema of intact skin (grade one [b] PU), an important independent predictor of Grade two PU development, increasing the odds approximately four to six-fold. This outcome will be used to monitor the sub-group of participants who, on entry to the study, did not present with any visible signs of pressure damage consistent with a grade one (b) PU.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026